Trial Profile
Phase1 trial of Cetuximab/S-1 combination therapy for Advanced/Recurrent Colorectal Cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 17 May 2016 New trial record